0
edits
Changes
no edit summary
<td> 32</td>
<td> PETA-3, SFA-1</td>
<td> Platelets, megakaryocytes, immature hematopoeitic cells, endothelial cells</td> <td> Adhesion molecule </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD152</strong></td>
<td bgcolor="#cccccc"> ~46, ~50</td> <td bgcolor="#cccccc"> Cytotoxic T lymphocyte-associated protein-4 (CTLA-4)</td> <td bgcolor="#cccccc"> Activated T cells, perhaps some activated B cells </td> <td bgcolor="#cccccc"> Negative regulator of T-cell activation</td>
</tr>
<tr>
<td><strong> CD153</strong></td>
<td> 38-40</td> <td> CD30 ligand, CD30L</td> <td> Activated T cells, activated macrophages, neutrophils, B cells</td> <td> Ligand for CD30, may co-stimulate T cells</td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD154</strong></td>
<td bgcolor="#cccccc"> 30</td> <td bgcolor="#cccccc"> CD40 ligand (CD40L), T-BAM, TNF-related activation protein (TRAP), gp39</td> <td bgcolor="#cccccc"> Activated CD4 cells</td> <td bgcolor="#cccccc"> Ligand for CD40, inducer of B-cell proliferation and activation</td>
</tr>
<tr>
<td><strong> CD155</strong></td>
<td> 80-90</td> <td> Poliovirus receptor (PVR) </td> <td> Monocytes, macrophages, thymocytes, CNS neurons</td> <td> Normal function unknown; receptor for poliovirus</td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD156</strong></td>
<td bgcolor="#cccccc"> 69</td> <td bgcolor="#cccccc"> ADAM8, MS2 human</td> <td bgcolor="#cccccc"> Neutrophils, monocytes</td> <td bgcolor="#cccccc"> Possible role in extravasation of leukocytes </td>
</tr>
<tr>
<td><strong> CD157</strong></td>
<td> 42-45, 50</td> <td> BP-3/IF-7, BST-1, Mo5</td> <td> Granulocytes, monocytes, macrophages, some B-cell progenitors, some T-cell progenitors</td> <td> Support for growth of pymphocyte progenitors</td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD158a</strong></td>
<td bgcolor="#cccccc"> 58, 50</td> <td bgcolor="#cccccc"> EB6, MHC class Ⅰ- specific receptors, p50,1, p58.1</td> <td bgcolor="#cccccc"> Subset of NK cell, some T cells</td> <td bgcolor="#cccccc"> Regulation of NK cell-mediated cytolytic activity upon interaction with the appropriate HLA-C alleles</td>
</tr>
<tr>
<td><strong> CD158b</strong></td>
<td> 58, 50</td> <td> GL183, MHV vlass Ⅰ-specific receptors, p50.2, p58.2 </td> <td> Subset of NK cells, some T cells</td> <td> Regulation of NK cell-mediated cytolytic activity upon interaction with the appropriate HLA-C alleles</td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD161</strong></td>
<td bgcolor="#cccccc"> ~80</td> <td bgcolor="#cccccc"> NKR-PIA </td> <td bgcolor="#cccccc"> Most NK cells, a subset of CD4+ and CD8+ T cells, thymocytes </td> <td bgcolor="#cccccc"> Modulation of NK cell-mediated cytotoxicity against certain Fc-receptor-bearing targets; induction of immature thymocyte proliferation</td>
</tr>
<tr>
<td><strong> CD162</strong></td>
<td> 250, 160, 220</td> <td> PSGL-1</td> <td> Most peripheral-blood T cells, monocytes, granulocytes, B cells</td> <td> Mediation of leukocyte rolling</td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD163</strong></td>
<td bgcolor="#cccccc"> 130</td> <td bgcolor="#cccccc"> GHI/61, M130 </td> <td bgcolor="#cccccc"> Not known </td> <td bgcolor="#cccccc"> Not known </td>
</tr>
<tr>
<td><strong> CD164</strong></td>
<td> 80</td> <td> MUC-24, multi-glycosylated core protein 24 (MGC-24v) </td> <td> Not known </td> <td> Not known</td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD165</strong></td>
<td bgcolor="#cccccc"> 37</td> <td bgcolor="#cccccc"> AD2, gp37</td> <td bgcolor="#cccccc"> Peripheral lymphocytes, immatyre thymocytes, monocytes, most platelets, thymocytes</td> <td bgcolor="#cccccc"> Adhesive interactions including adhesion between thymocytes and thymic epithelial cells</td>
</tr>
</tbody>
</table>